Next Article in Journal
Advances in Spinal Cord Stimulation
Next Article in Special Issue
Characterization of Perinatal Stem Cell Spheroids for the Development of Cell Therapy Strategy
Previous Article in Journal
Computing Drug-Drug Similarity from Patient-Centric Data
Previous Article in Special Issue
Vascularized Tissue Organoids
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Bioengineering
Volume 10
Issue 2
10.3390/bioengineering10020183
bioengineering-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Release in Pancreatic Cancer

by
Carmen Cepeda-Franco
1,2,*,†,
Oihane Mitxelena-Iribarren
3,4,†,
Francisco José Calero-Castro
1,2,*,
Malen Astigarraga
3,
Juan M. Castillo-Tuñon
5,
Iman Laga
1,2,
Sheila Pereira
1,2,
Sergio Arana
3,4,
Maite Mujika
3,4,‡ and
Javier Padillo-Ruiz
1,2,‡
1
Department of General Surgery, Virgen del Rocio University Hospital, 41013 Seville, Spain
2
Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain
3
CEIT-Basque Research and Technology Alliance (BRTA), 20008 Donostia-San Sebastián, Spain
4
Tecnun, Universidad de Navarra, 20018 Donostia-San Sebastián, Spain
5
Department of General Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain
*
Authors to whom correspondence should be addressed.
†
These authors have contributed equally to this work.
‡
These authors have contributed equally to this work.
Bioengineering 2023, 10(2), 183; https://doi.org/10.3390/bioengineering10020183
Submission received: 27 December 2022 / Revised: 17 January 2023 / Accepted: 27 January 2023 / Published: 1 February 2023
(This article belongs to the Special Issue 3D Cell Culture in Disease Modeling and Tissue Regeneration)
Browse Figures
Review Reports Versions Notes

Abstract

Post-surgical chemotherapy in pancreatic cancer has notorious side effects due to the high dose required. Multiple devices have been designed to tackle this aspect and achieve a delayed drug release. This study aimed to explore the controlled and sustained local delivery of a reduced drug dose from an irinotecan-loaded electrospun nanofiber membrane (named TARTESSUS) that can be placed on the patients’ tissue after tumor resection surgery. The drug delivery system formulation was made of polycaprolactone (PCL). The mechanical properties and the release kinetics of the drug were adjusted by the electrospinning parameters and by the polymer ratio between 10 w.t.% and 14 w.t.% of PCL in formic acid:acetic acid:chloroform (47.5:47.5:5). The irinotecan release analysis was performed and three different release periods were obtained, depending on the concentration of the polymer in the dissolution. The TARTESSUS device was tested in 2D and 3D cell cultures and it demonstrated a decrease in cell viability in 2D culture between 72 h and day 7 from the start of treatment. In 3D culture, a decrease in viability was seen between 72 h, day 7 (p < 0.001), day 10 (p < 0.001), 14 (p < 0.001), and day 17 (p = 0.003) as well as a decrease in proliferation between 72 h and day 10 (p = 0.030) and a reduction in spheroid size during days 10 (p = 0.001), 14 (p < 0.001), and 17 (p < 0.001). In conclusion, TARTESSUS showed a successful encapsulation of a chemotherapeutic drug and a sustained and delayed release with an adjustable releasing period to optimize the therapeutic effect in pancreatic cancer treatment.
Keywords: electrospinning; nanofiber membrane; pancreatic cancer; drug delivery system; irinotecan electrospinning; nanofiber membrane; pancreatic cancer; drug delivery system; irinotecan

Share and Cite

MDPI and ACS Style

Cepeda-Franco, C.; Mitxelena-Iribarren, O.; Calero-Castro, F.J.; Astigarraga, M.; Castillo-Tuñon, J.M.; Laga, I.; Pereira, S.; Arana, S.; Mujika, M.; Padillo-Ruiz, J. TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Release in Pancreatic Cancer. Bioengineering 2023, 10, 183. https://doi.org/10.3390/bioengineering10020183

AMA Style

Cepeda-Franco C, Mitxelena-Iribarren O, Calero-Castro FJ, Astigarraga M, Castillo-Tuñon JM, Laga I, Pereira S, Arana S, Mujika M, Padillo-Ruiz J. TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Release in Pancreatic Cancer. Bioengineering. 2023; 10(2):183. https://doi.org/10.3390/bioengineering10020183

Chicago/Turabian Style

Cepeda-Franco, Carmen, Oihane Mitxelena-Iribarren, Francisco José Calero-Castro, Malen Astigarraga, Juan M. Castillo-Tuñon, Iman Laga, Sheila Pereira, Sergio Arana, Maite Mujika, and Javier Padillo-Ruiz. 2023. "TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Release in Pancreatic Cancer" Bioengineering 10, no. 2: 183. https://doi.org/10.3390/bioengineering10020183

APA Style

Cepeda-Franco, C., Mitxelena-Iribarren, O., Calero-Castro, F. J., Astigarraga, M., Castillo-Tuñon, J. M., Laga, I., Pereira, S., Arana, S., Mujika, M., & Padillo-Ruiz, J. (2023). TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Release in Pancreatic Cancer. Bioengineering, 10(2), 183. https://doi.org/10.3390/bioengineering10020183

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop